CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia.
Zheng NS, Zhao XY, Wei D, Miao JL, Liu ZK, Yong YL, Zhang RY, Guo YX, He L, Wang B, Sun XX, Yang HJ, Zhang TJ, He Q, Li XM, Zhang H, Hou R, Lin P, Xu YM, Huang XJ, Chen ZN, Bian H.
Zheng NS, et al. Among authors: yong yl.
Cancer Lett. 2022 Aug 28;542:215762. doi: 10.1016/j.canlet.2022.215762. Epub 2022 May 31.
Cancer Lett. 2022.
PMID: 35659513